(Q50434295)

English

Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.

scientific article published on 16 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

author name string

Wei-Wei Xiao

1

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Shao-Min Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Shao-Xiong Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Li-Xia Lu

5

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Cheng-Guang Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Xiao-Wu Deng

7

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Tai-Xiang Lu

8

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Nian-Ji Cui

9

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Chong Zhao

10

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

language of work or name

0 references

publication date

16 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

117

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

9

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

1874-1883

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Prognostic Factors Affecting the Outcome of Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Dose-response analysis for nasopharyngeal carcinoma: an historical perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

High-dose, high-precision treatment options for boosting cancer of the nasopharynx

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

21 January 2018

Irradiation of nasopharyngeal carcinoma: correlations with treatment factors and stage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose–response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma--an analysis of 1446 cases with squamous cell carcinoma grade 3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25754

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25754

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/21509764

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50434295&oldid=1584455523"